Notice of Annual General Meeting 2019
The shareholders of IDL Biotech AB (publ) are hereby invited to the Annual General Meeting on Tuesday, 28 May 2019, 15.00 at Redeye AB, Mäster Samuelsgatan 42, 10387 Stockholm.
IDL Biotech AB - provides knowledge to decision
IDL Biotech is a diagnostic company that develops, produces, and markets In Vitro Diagnostic (IVD) tests worldwide for the health care sector. We are active in the fields of oncology and bacteriology through manufacturing of various tumor markers and a rapid Salmonella typhoid test. IDL Biotech AB (publ) is a public company listed on the Swedish equities market place, Spotlight Stock Market.
IDL in the Spotlight
Spotlight has produced a short film about IDL Biotech.
German study recommends UBC® Rapid to be added in the diagnostics and follow-up of high risk bladder cancer
International Journal of Molecular Sciences has published a study on UBC® Rapid. In total 530 urine samples was included in the multicenterstudy.
